Pregnancy rate · women having endometriosis surgery
It is very uncertain whether presurgical medical therapy changes pregnancy rate (dichotomous) compared with postsurgical medical therapy (very low certainty).
1 finding from 1 review
Pain recurrence (dichotomous) Pain recurrence ≤ 12 months · women having endometriosis surgery
It is very uncertain whether presurgical medical therapy changes pain recurrence (dichotomous) Pain recurrence ≤ 12 months compared with placebo or no medical therapy (very low certainty).
1 finding from 1 review
Disease recurrence at 3 months – total (AFS score) · women having endometriosis surgery
1 finding from 1 review
Recurrence · women having endometriosis surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease recurrence ≤ 12 months (EEC stage) · women having endometriosis surgery
It is very uncertain whether presurgical medical therapy changes disease recurrence ≤ 12 months (EEC stage) compared with placebo or no medical therapy (very low certainty).
1 finding from 1 review
Pregnancy rate · women having endometriosis surgery
It is very uncertain whether presurgical medical therapy changes pregnancy rate (dichotomous) compared with placebo or no medical therapy (very low certainty).
1 finding from 1 review
Pelvic pain · women having endometriosis surgery
1 finding from 1 review
Pain recurrence (dichotomous) Pain recurrence ≤ 12 months · women having endometriosis surgery
Postsurgical medical therapy may leads to lower pain recurrence (dichotomous) Pain recurrence ≤ 12 months compared with placebo or no medical therapy (low certainty).
1 finding from 1 review
Disease recurrence at 12 months – total (AFS score) · women having endometriosis surgery
1 finding from 1 review
Uterine volume (cm³) · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fibroid volume (cm³) · women with uterine fibroids
1 finding from 1 review
Haemoglobin (g/dL) · women with uterine fibroids
1 finding from 1 review
Preoperative bleeding: (PBAC < 75) ulipristal acetate 5 mg · women with uterine fibroids
GnRHa treatment showed no clear difference in preoperative bleeding: Reduction in bleeding to PBAC < 75 ulipristal… compared with other medical therapies before any surgery (moderate certainty).
1 finding from 1 review
Preoperative bleeding: Reduction in bleeding to PBAC < 75 ulipristal acetate 10 mg · women with uterine fibroids
GnRHa treatment showed no clear difference in preoperative bleeding: Reduction in bleeding to PBAC < 75 ulipristal… compared with other medical therapies before any surgery (moderate certainty).
1 finding from 1 review
Adverse events (hot flushes) · women with uterine fibroids
GnRHa treatment may leads to higher adverse events (hot flushes) compared with other medical therapies before any surgery (low certainty).
1 finding from 1 review
Postoperative ileus · Women who had major abdominal gynaecologic surgery
Early oral feeding showed no clear difference in postoperative ileus compared with delayed oral feeding (moderate certainty).
1 finding from 1 review
Maternal nausea and/or vomiting · Women who had major abdominal gynaecologic surgery
Early oral feeding showed no clear difference in nausea or vomiting or both compared with delayed oral feeding (moderate certainty).
1 finding from 1 review
Time to bowel sounds [days] · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Time from completion of operation to first flatus (hours) · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Postoperative time to solid diets (days) · Women who had major abdominal gynaecologic surgery
1 finding from 1 review